ISCT signs memorandum of understanding with ARM

PCT Team | April 7, 2016

April 5, 2016 - The International Society for Cellular Therapy (ISCT), theglobal society of clinicians, researchers, regulators, technologists, and industry partners dedicated to the translation of cellular therapy into safe and effective therapies to improve patients’ lives, today announces the signing of amemorandum of understanding (MOU) with the Alliance for Regenerative Medicine (ARM), the international organization representing the gene and cellular therapies and the regenerative medicine sector.

The agreement has been signed by Massimo Dominici, M.D., ISCT President, and Morrie Ruffin, ARM Managing Director. ISCT will become an honorary member of ARM, and vice versa. This agreement will extend collaborations between the two international organizations. Since ARM’s establishment in 2009, both organizations have collaborated on a series of projects, including authoring white papers. ARM and ISCT members have held leadership roles in both organizations.

Click here to read the full article.

PCT Team

PCT Team Our leaders have worked on some of the major cell therapies of the past 10 years, and have extensive experience in pharmaceutical-grade quality and operations.

Subscribe to our blog for instant updates on challenges and trends in cell therapy development, manufacturing and commercialization.

Subscribe to Email Updates